Trent:₹3,256.10+30.96 (+0.96%)
Reliance Industries:₹1,377.50+1.93 (+0.14%)
Adani Ports:₹1,917.00-0.19 (-0.01%)
Tata Consumer:₹1,155.90+11.90 (+1.04%)
Titan Company:₹4,620.00-79.90 (-1.70%)
TCS:₹2,376.20+33.50 (+1.43%)
Trent:₹3,256.10+30.96 (+0.96%)
Reliance Industries:₹1,377.50+1.93 (+0.14%)
Adani Ports:₹1,917.00-0.19 (-0.01%)
Tata Consumer:₹1,155.90+11.90 (+1.04%)
Titan Company:₹4,620.00-79.90 (-1.70%)
TCS:₹2,376.20+33.50 (+1.43%)
Refer & Earn
Arihant Plus App

Arihant Plus App

Gaudium IVF and Women Health Ltd

Gaudium IVF | 544709

Market Closed
₹99.57
+₹0.13 (+0.13%)
As on 22/11/26, 4:24 AM
Market Cap723.79 CR
Current Price₹99.57
High / Low₹163.18 / 69.18
PE Ratio21.22
Book Value₹20.92
Dividend Yield0.00%
ROCE29.45%
ROE22.90%
Face Value₹2.00
Current Vol.1,70,505
Average Vol.---
ISININE0P8B01020
PB Ratio3.41
Debt to Equity0.23
Net Profit Margin23.44
Operating Margin36.95

GAUDIUMIVF - Share Price Chart

+₹0.00 (+0.00%)6M

Stock Performance

₹99.44₹98
₹99.57
Previous CloseToday's Open
₹69.18₹163.18
₹99.57
52W Low52W High
₹98Today's Open
₹99.44Previous Close
1,70,505Volume
₹69.1852W Low
₹163.1852W High

Ratios

No data available

About Company

  • Gaudium IVF and Women Health Limited was originally incorporated in the name of 'Gaudium IVF and Women Health Private Limited' as a Private Limited Company, dated March 24, 2015 with the RoC, Delhi and Haryana
  • Subsequently, the status of the Company was converted from a Private Limited into a Public Limited and the name was changed to Gaudium IVF and Women Health Limited', and a fresh Certificate of Incorporation dated October 24, 2024 was issued by the Central Processing Center
  • The Company is engaged in providing In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), fertility preservation, and other Assisted Reproductive Technology (ART) and women's healthcare services across India, expanding its reach through a strategic alliance with infertility experts to promote awareness of ART and IVF treatments
  • Its facilities provide a comprehensive range of male infertility treatments, including advanced sperm retrieval techniques
  • For fertility preservation, Company offer cryopreservation services for eggs freezing for future fertilization, utilizing advanced technology to ensure optimal success rates in future IVF cycles
  • It further provide laparoscopic and hysteroscopic surgeries for the diagnosis and treatment of infertility-related conditions, as well as genetic testing options, including Preimplantation Genetic Testing (PGT), designed to enhance pregnancy outcomes and mitigate the risks of genetic disorders
  • The Company began its journey by starting the business operations at Gaudium Hospital in 2019
  • Gaudium IVF and Gynae Solutions, a proprietary firm of Dr
  • Manika Khanna, was acquired by the Company with the main object clause, pursuant to a preferential allotment dated March 29, 2021
  • This acquisition was executed through the issuance of 9,40,232 equity shares

Research Calls

Research Calls
Locked Access

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSI42.48
SMA 20103.82
SMA 50106.72
SMA 100117.44
SMA 200N/A
SMA 10103.92
MACD_12_26_Days-1.43
EMA10Day102.31
EMA20Day103.43
EMA50Day107.05
MACD_12_26_9_Days-0.46
EMA100Day108.82
EMA200Day109.96

Pivot Points

Volume Analysis

Delivery
Total Volume

Growth Rate

Revenue Growth47.57%
ROE24.63%
EBITDA Margin36.95%

All figures in ₹ Crores

Indicators20262025202420232022
Revenue
104.36
70.72
47.89
44.24
36.52
Interest
3.49
1.39
0.75
0.34
0.45
Expenses
66.65
42.10
28.62
24.17
23.10
Financing Profit
38.24
28.86
19.54
20.09
13.42
Financing Margin %
37%
41%
41%
45%
37%
Other Income
0.53
0.23
0.26
0.02
0.00
Depreciation
2.55
2.05
2.16
1.43
0.97
Profit before tax
32.20
25.42
16.63
18.31
12.00
Tax %
24%
25%
38%
26%
26%
Net Profit
24.49
19.13
10.32
13.52
8.83
EPS in Rs
3.92
3.12
1.68
2.20
1.44
Show % Change
ShareHolding
📊

No Information Available

No shareholding data available at this time.

📊

No Data Available

No Block Deals data available for this company.

News

18 Nov 2026 12:00 am

Sanofi Consumer Healthcare India Ltd Spurts 3.52%

Sanofi Consumer Healthcare India Ltd Spurts 3.52%

Record Date
Corporate Action
Information
Announcement Day
28 Sept 2026
AGM
AGM
13 Aug 2026

Peers

LTP(₹)
Market Cap(₹ Cr.)
P/E Ratio(Ratio)
P/B Ratio(Ratio)
Cash Earnings(Ratio)
Debt to Equity(Ratio)
Net Profit Ratio(%)
100
726
31
4
27
0
23.44%
9,190
1,32,139
58
12
42
1
7.94%
1,080
1,05,080
74
9
55
0
17.23%
702
92,366
95
6
53
1
8.87%
780
67,960
123
9
75
1
9.20%
825
62,284
58
6
40
0
11.20%
1,481
39,829
62
9
44
0
12.56%
1,945
39,757
44
8
27
1
10.21%
2,007
33,680
56
12
43
0
18.45%
797
33,483
165
9
57
2
6.20%
Showing 10 of 71 Results

Frequently Asked Questions

What is Share Price of Gaudium IVF and Women Health Ltd?

The current share price of Gaudium IVF and Women Health Ltd (Gaudium IVF) is ₹99.57. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Gaudium IVF and Women Health Ltd?

The Price-to-Earnings (P/E) ratio of Gaudium IVF and Women Health Ltd is 31.23. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Gaudium IVF and Women Health Ltd?

Gaudium IVF and Women Health Ltd has a 52-week high of ₹163.18 and a 52-week low of ₹69.18. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Gaudium IVF and Women Health Ltd?

Gaudium IVF and Women Health Ltd offers a dividend yield of 0.00%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Gaudium IVF and Women Health Ltd?

The Earnings Per Share (EPS) of Gaudium IVF and Women Health Ltd is ₹3.18. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Gaudium IVF and Women Health Ltd?

Gaudium IVF and Women Health Ltd has a Return on Equity (ROE) of 22.90%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

mobile

Ready to invest smarter?
Download the app today.

GET IT ON

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

DOWNLOAD ON THE

App Store

4.2